Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Moderna (MRNA)
NASDAQ:MRNA
Moderna (MRNA) Stock Price & Analysis
14,062 Followers
MRNA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$86.24 - $217.25
Previous Close$86.33
Volume4.69M
Average Volume (3M)3.96M
Market Cap
$32.86B
Enterprise Value$25.34B
Total Cash (Recent Filing)$8.46B
Total Debt (Recent Filing)$947.00M
Price to Earnings (P/E)31.7
Beta1.07
Next Earnings
Nov 02, 2023EPS Estimate
-$1.9Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.72
Shares Outstanding380,592,588
10 Day Avg. Volume3,366,089
30 Day Avg. Volume3,960,245
Standard Deviation0.27
R-Squared0.11
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)2.21
Price to Sales (P/S)101.72
Price to Cash Flow (P/CF)-10.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.67
Enterprise Value/Gross Profit1.83
Enterprise Value/Ebitda-46.42
Forecast
1Y Price Target
$160.61Price Target Upside86.73% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
Moderna News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MRNA FAQ
What was Moderna’s price range in the past 12 months?
Moderna lowest stock price was $86.24 and its highest was $217.25 in the past 12 months.
What is Moderna’s market cap?
Currently, no data Available
When is Moderna’s upcoming earnings report date?
Moderna’s upcoming earnings report date is Nov 02, 2023 which is in 14 days.
How were Moderna’s earnings last quarter?
Moderna released its earnings results on Aug 03, 2023. The company reported -$3.62 earnings per share for the quarter, beating the consensus estimate of -$3.935 by $0.315.
Is Moderna overvalued?
According to Wall Street analysts Moderna’s price is currently Undervalued.
Does Moderna pay dividends?
Moderna does not currently pay dividends.
What is Moderna’s EPS estimate?
Moderna’s EPS estimate is -$1.9.
How many shares outstanding does Moderna have?
Moderna has 380,592,600 shares outstanding.
What happened to Moderna’s price movement after its last earnings report?
Moderna reported an EPS of -$3.62 in its last earnings report, beating expectations of -$3.935. Following the earnings report the stock price went down -0.245%.
Which hedge fund is a major shareholder of Moderna?
Among the largest hedge funds holding Moderna’s share is Flagship Pioneering Inc.. It holds Moderna’s shares valued at 2B.
---
Moderna Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$160.61 (86.73% Upside)
$160.61 (86.73% Upside)
Blogger Sentiment
Bullish
MRNA Sentiment 69%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 80.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days >0.1%
Last 30 Days ▲ 2.1%
Last 30 Days ▲ 2.1%
News Sentiment
Very Negative
Bullish news 20%
Bearish news 80%
Bearish news 80%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-38.00%
12-Months-Change
Fundamentals
Return on Equity
6.91%
Trailing 12-Months
Asset Growth
-15.97%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Moderna
Incorporated in 2010, Massachusetts-based Moderna, Inc. is a clinical stage biotechnology company which develops therapeutics and vaccines based on messenger ribonucleic acid (mRNA) for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics.
---
Top 5 ETFs holding MRNA
Global X S&P 500 Covered Call ETF
$2.66M
iShares ESG Screened S&P 500 ETF
$156.99K
Global X S&P 500 Covered Call & Growth ETF
$54.02K
Global X S&P 500 ESG Covered Call ETF
$2.57K
Global X S&P 500 Tail Risk ETF
$2.52K
Up to five ETFs with an Outperform Smart Score that hold MRNA. The ETFs are listed according to market value of MRNA within the ETF
---